For Allergy Awareness Week, we speak to Kitt Medical's Zak Marks, whose experience with severe allergies sparked a mission to ...

Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch and ...

As Minneapolis lays out its summer public safety plans, the city’s violence interrupter groups are challenging new requirements in their proposed contracts. A Minneapolis man will be sentenced ...

TNX-801 is a single-dose, live virus vaccine in development to protect against mpox and smallpox. TNX-801 protects immunocompromised animals from a lethal challenge with clade IIa ...